Publication date: Aug 07, 2024
Emergent tremor in Parkinson’s disease (PD) can occur during sustained postures or movements that are different from action tremor. Tremor can contaminate the clinical rating of bradykinesia during finger tapping. Currently, there is no reliable way of isolating emergent tremor and measuring the cardinal motor symptoms based on voluntary movements only. In this study, we investigated whether emergent tremor during repetitive alternating finger tapping (RAFT) on a quantitative digitography (QDG) device could be reliably identified and distinguished from voluntary tapping. Ninety-six individuals with PD and forty-two healthy controls performed a thirty-second QDG-RAFT task and the Movement Disorders Society – Unified Parkinson’s Disease Rating Scale Part III (MDS-UPDRS III). Visual identification of tremor during QDG-RAFT was labeled by an experienced movement disorders specialist. Two methods of identifying tremor were investigated: 1) physiologically informed temporal thresholds 2) XGBoost model using temporal and amplitude features of tapping. The XGBoost model showed high accuracy for identifying tremor (area under the precision-recall curve of 0. 981) and outperformed temporal-based thresholds. Percent time duration of classifier-identified tremor showed significant correlations with MDS-UPDRS III tremor subscores (r = 0. 50, p
Open Access PDF
Concepts | Keywords |
---|---|
Digitography | Based |
Drugs | Emergent |
Parkinsons | Finger |
Quantitative | Identified |
Raft | Iii |
Investigated | |
Movements | |
Parkinson | |
Qdg | |
Raft | |
Rating | |
Tapping | |
Temporal | |
Tremor | |
Voluntary |
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | Parkinson’s disease |
disease | MESH | postures |
disease | MESH | Movement Disorders |
disease | MESH | gait |
drug | DRUGBANK | Cysteamine |
drug | DRUGBANK | Trestolone |
drug | DRUGBANK | Esomeprazole |
pathway | REACTOME | Release |